Willis Towers Watson to acquire TRANZACT for $1.2B

Apr. 01, 2019 5:58 AM ETWillis Towers Watson Public Limited Company (WTW)By: Niloofer Shaikh, SA News Editor
  • Willis Towers Watson (WLTW) has acquired TRANZACT for $1.2B, comprises of $1.1B of cash consideration and $100M of cash or stock consideration payable at close.
  • John Haley, CEO of Willis Towers Watson, said, “We are delighted to announce the acquisition of TRANZACT which represents a significant growth opportunity in the direct-to-consumer U.S. health care space and speaks to Willis Towers Watson’s renewed focus on strategic M&A opportunities. This deal will accelerate our direct-to-consumer strategy and help create an end-to-end consumer acquisition platform.”
  • The transaction is expected to close in 3Q19 and will be immediately accretive to company on an adjusted earnings per share basis.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.